
Keywords: A; alanine; AOP; adverse outcome pathway; C; cysteine; Cys; cysteine; DNCB; 2,4-Dinotrochlorobenzene; DPRA; direct peptide reactivity assay; EGDMA; Ethylene glycol dimethacrylate; F; phenylalanine; FN; false negative; FP; false positive; GHS; Global harmo